For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Alzheimer's Disease and Angiogenesis
暂无分享,去创建一个
A. Vagnucci | William W. Li | H. School | Ma Boston | A. H. Vagnucci | W. W. Li | Md | William W Li
[1] Tomás Pantoja,et al. Análisis crítico de un artículo Las estatinas reducen la morbi-mortalidad en pacientes de alto riesgo cardiovascular: Heart Protection Study Collaborative Group. (HPS). Lancet 2002; 360: 7-22. , 2003 .
[2] D. Thal,et al. Aberrant Neuronal and Paracellular Deposition of Endostatin in Brains of Patients with Alzheimer's Disease , 2002, The Journal of Neuroscience.
[3] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[4] B. Rouse,et al. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. , 2002, The Journal of clinical investigation.
[5] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[6] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.
[7] B. Rouse,et al. DNA containing CpG motifs induces angiogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] Anders Wallin,et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia , 2002, Neurobiology of Aging.
[9] Kenneth Rockwood,et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. , 2002, Archives of neurology.
[10] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[11] Rong Wang,et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.
[12] P. Grammas,et al. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease , 2001, Neurobiology of Aging.
[13] R. Pyles. The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors. , 2001, Herpes : the journal of the IHMF.
[14] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[15] C. Lemere,et al. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. , 2001, The American journal of pathology.
[16] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[17] E. Manseau,et al. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. , 2001, The American journal of pathology.
[18] H Jick,et al. Statins and the risk of dementia , 2000, The Lancet.
[19] G. Celesia,et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.
[20] K. Kinzler,et al. Genes expressed in human tumor endothelium. , 2000, Science.
[21] N. Bundred,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Angiogenesis In Vitro and In Vivo , 2000 .
[22] Q. Peng,et al. Pycnogenol protects vascular endothelial cells from β-amyloid-induced injury. , 2000 .
[23] Q. Peng,et al. Pycnogenol protects vascular endothelial cells from beta-amyloid-induced injury. , 2000, Biological & pharmaceutical bulletin.
[24] P. López-Saura,et al. [Alpha interferon and Alzheimer's disease]. , 2000, Revista de neurologia.
[25] J. Hoffman,et al. Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. , 2000 .
[26] E. Levin,et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing , 1999, Nature Medicine.
[27] N. Tsopanoglou,et al. On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.
[28] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[29] A. Dabrowska,et al. Lovastatin and tumor necrosis factor‐α exhibit potentiated antitumor effects against Ha‐ras‐transformed murine tumor Via inhibition of tumor‐induced angiogenesis , 1999, International journal of cancer.
[30] H. Figueiredo,et al. Thrombin Induces Surface and Intracellular Secretion of Amyloid Precursor Protein from Human Endothelial Cells , 1999, Thrombosis and Haemostasis.
[31] P. Weigel,et al. Microvessels from Alzheimer's disease brains kill neurons in vitro. , 1999, The American journal of pathology.
[32] Yoshihiro Sato,et al. High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. , 1998, Bone.
[33] J. LaManna,et al. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. , 1998, Brain research. Molecular brain research.
[34] J. Tuomilehto,et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.
[35] T. Miyakawa. Electron Microscopy of Amyloid Fibrils and Microvessels , 1997, Annals of the New York Academy of Sciences.
[36] P. Hof,et al. Brain Microvascular Changes in Alzheimer's Disease and Other Dementias a , 1997, Annals of the New York Academy of Sciences.
[37] W F Stewart,et al. Risk of Alzheimer's disease and duration of NSAID use , 1997, Neurology.
[38] G. Wilcock,et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease , 1997, The Lancet.
[39] Patrick L. McGeer,et al. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.
[40] M. Pericak-Vance,et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs , 1995, Neurobiology of Aging.
[41] D. Selkoe,et al. Calcium ionophore increases amyloid beta peptide production by cultured cells. , 1994, Biochemistry.
[42] W. McDonald,et al. Inverse association of anti‐inflammatory treatments and Alzheimer's disease , 1994, Neurology.
[43] J. Morrison,et al. Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease. , 1992, The American journal of pathology.
[44] M. Somerville,et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.
[45] P. Cras,et al. Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[46] H. DeLuca,et al. Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[47] H. Chui,et al. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease , 1990, Brain Research.
[48] T. Tsuchida,et al. Effects of cimetidine and omeprazole on angiogenesis in granulation tissue of acetic acid-induced gastric ulcers in rats. , 1990, Digestion.
[49] A. Lbert,et al. Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease , 2022 .